Docstoc

08_cancer_treatment

Document Sample
08_cancer_treatment Powered By Docstoc
					New Cancer Treatment may prevent Chemo Patient’s Hair Loss and Nausea
For Release- Friday July 18, 2008
Greensboro, NC- July 18, 2008 The University of North Carolina Greensboro (UNCG) and the NC NanoAccelerator (NCNA) have joined forces to develop a revolutionary new method of treating of cancerous tumors with far less side effects of any current treatment. Developed in UNCG’s Center for Research Excellence in Nanobiosciences (CREN), this is the first innovation licensed to the NC NanoAccelerator, a resource designed to provide new technologies a quick route to commercialization. The work will be done in a newly formed company, Thermiacure Corp. The novelty of the new technology stems for the ability to deliver the cancer killing treatment directly to the various tumor sites. Thus very small amounts are needed vs. existing treatments that attack the entire body. Surprisingly, the carrier for the treatment is a specially treated strain of bacteria. They are non pathogenic and will “seek out” tumors, ignoring healthy cells. The carriers are also excellent imaging agents for an MRI. This enables the physician to insure they are in the proper location, at the tumor sites, before triggering the release of the chemo and hyperthermia. This release is part of the “magic” in the treatment; it is done by pulsing a magnetic field. There are significant advantages to this novel use of tumor seeking bacteria: 1. Less cancer killing material is required and it need not be placed into the tumor by invasive surgery. It can be placed into the blood by a simple IV tube and will seek the tumors. 2. The significantly lower dose of medicine almost eliminates side effects such as loss of hair, nausea and general weakness. 3. By improving the contrast of the particles they are easier to trace by an MRI insuring that they reside in the tumor site and allows for capturing any that go astray. 4. The tumor is effectively treated while healthy cells are not exposed. Dr. Rosemary Wander, Associate Provost for Research and Public / Private Sector Partnerships at UNCG said, “This technology is exciting and holds the promise of significant benefits to cancer patients worldwide. This is a major step for UNCG’s focus on entrepreneurial efforts coming from research on campus.” Dr. Yousef Haik, head of CREN said, “I am delighted to see my work given the support and direction needed to achieve FDA approval and reach the market as quickly as possible. This validates our nanobioscience research at CREN and will encourage us to move quickly with other work underway.” Center for Research Excellence in Nanobiosciences was established in late 2006 by a grant from the state as a Center for innovations in nano-bioscience.

Dr. Reyad Sawafta, President of NCNA and CEO of host QuarTek, said, “We are pleased to be working closely with UNCG and CREN on the commercialization of this impressive innovation. It is in line with our mission to introduce innovations at the forefront of nanotechnology for the benefit of mankind and it also holds significant commercial potential.” The Carnegie Foundation for the Advancement of Teaching has classified UNCG a research university with “high research activity.” Under the guidance of the recently retired Chancellor, Dr. Sullivan and Dr. Wander, UNCG has seen an increase in its research funding and in its efforts to commercialize the innovations resulting from the activities of its faculty, staff and students. NCNA was established in 2006 by QuarTek as a way for start-up companies in related fields to reach “maturity” and commercial success efficiently. We believe this is the only organization of its kind in the US. QuarTek Corp. was established in 2004 as the first North Carolina based nanotechnology research company. Located at 4180 Piedmont Parkway in Greensboro, NC 27410. QuarTek is headed by Reyad Sawafta, PhD, President and CEO. For further information Contact: Jerry McGuire, Director Tech Transfer Office, UNCG mcguirej@uncg.edu Dr. Reyad Sawafta, President, QuarTek Rsawafta@quartekcorp.com Dixon Johnston COO, NC NanoAccelerator dxdj@earthlink.net (336) 256-1298

(336) 316-0088 x208

(336) 316-0088 x206


				
DOCUMENT INFO